News
Perrigo Secures Binding Offer To Divest Its HRA Pharma Rare Diseases Business For Up To €275M
25 Apr 24
News, Asset Sales
Canaccord Genuity Maintains Buy on Perrigo, Maintains $42 Price Target
12 Apr 24
News, Price Target, Analyst Ratings
Disney To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
8 Apr 24
News, Price Target, Small Cap, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas
Piper Sandler Maintains Overweight on Perrigo, Raises Price Target to $39
8 Apr 24
News, Price Target, Analyst Ratings
CVS Health's Zero-Cost Coverage Paves Way For OTC Birth Control Access
5 Apr 24
Large Cap, News, Health Care, General
'Supreme Court Unlikely To Limit Access To Abortion Pill' - Washington Post
26 Mar 24
Biotech, News, Legal, General
Perrigo Commences Shipments Of Opill To Retailers Nationwide
4 Mar 24
News
Around $2M Bet On Tile Shop Holdings? Check Out These 4 Stocks Insiders Are Buying
1 Mar 24
Long Ideas, News, Small Cap, Insider Trades, Pre-Market Outlook, Markets, Trading Ideas
JP Morgan Maintains Overweight on Perrigo, Lowers Price Target to $41
28 Feb 24
News, Price Target, Analyst Ratings
OTC Medicine Player Perrigo Outlines Three-Year Cost Saving Plan, Posts Mixed Q4 Earnings
27 Feb 24
Earnings, News, Guidance, Health Care, Previews, General
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
27 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Perrigo Will Launch 'Project Energize' Investment And Efficiency Program In Q1 2024 To Drive Its One Perrigo Sustainable, Value Accretive Growth Strategy ; Restructuring Is Expected To Impact Approximately 6% Of Perrigo Roles
27 Feb 24
Earnings, News, Health Care, General
Perrigo Q4 Adjusted EPS $0.86 Beats $0.83 Estimate, Sales $1.16B Miss $1.18B Estimate
27 Feb 24
Earnings, News
Earnings Scheduled For February 27, 2024
27 Feb 24
Earnings
Perrigo Increases Its Quarterly Dividend 1% From $0.273 To $0.276 Per Share
26 Feb 24
News, Dividends
Press releases
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million
25 Apr 24
Press Releases
Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024
23 Apr 24
Press Releases
Opill and WNBA Team Up for Groundbreaking Partnership
9 Apr 24
News, Contracts, Press Releases
Perrigo Commences Shipments of Opill® to Retailers Nationwide, Empowering Millions to Enter a New Era of Reproductive Health Access in the United States
4 Mar 24
Press Releases
Perrigo to Attend UBS Global Consumer and Retail Conference
29 Feb 24
Press Releases
Perrigo Reports Fourth Quarter & Fiscal Year 2023 Financial Results From Continuing Operations; Launches Investment & Efficiency Program
27 Feb 24
Earnings, Press Releases
Perrigo Increases its Quarterly Dividend
26 Feb 24
Dividends, Press Releases
Perrigo to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 27, 2024
13 Feb 24
Press Releases